Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy.
Sung Wook YangGi Hyun KimJung Wha ChungHyung Rae SohnSang Soo LeeSukho HongSeong Min ChungEun Sun JangSook-Hyang JeongJin-Wook KimPublished in: Journal of gastroenterology and hepatology (2016)
Delayed AFP response to ETV may serve as an indicator of high HCC risk.